Fonar Corp's fundamentals are relatively very healthy, with low ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 123 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Fonar Corp's Score
Industry at a Glance
Industry Ranking
123 / 208
Overall Ranking
322 / 4563
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Fonar Corp Highlights
StrengthsRisks
FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment, and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, compliance consulting, purchasing, information technology (IT) services, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
Overvalued
The company’s latest PE is 16.41, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.92M shares, decreasing 17.74% quarter-over-quarter.
FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment, and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, compliance consulting, purchasing, information technology (IT) services, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
Ticker SymbolFONR
CompanyFonar Corp
CEODamadian (Timothy R)
Websitehttps://www.fonar.com/
FAQs
What is the current price of Fonar Corp (FONR)?
The current price of Fonar Corp (FONR) is 18.610.
What is the symbol of Fonar Corp?
The ticker symbol of Fonar Corp is FONR.
What is the 52-week high of Fonar Corp?
The 52-week high of Fonar Corp is 18.860.
What is the 52-week low of Fonar Corp?
The 52-week low of Fonar Corp is 12.000.
What is the market capitalization of Fonar Corp?
The market capitalization of Fonar Corp is 121.92M.
What is the net income of Fonar Corp?
The net income of Fonar Corp is 7.80M.
Is Fonar Corp (FONR) currently rated as Buy, Hold, or Sell?
According to analysts, Fonar Corp (FONR) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Fonar Corp (FONR)?
The Earnings Per Share (EPS TTM) of Fonar Corp (FONR) is 1.134.